U.S. Market to Reach USD 594.3 Million and Europe USD 526.6 Million by 2035 as HDR Procedures and Image-Guided Treatment Expand

Austin, Texas, Aug. 27, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Brachytherapy Market was valued at USD 1,092.0 Million in 2025 and is projected to reach USD 2,194.0 Million by 2035, growing at a CAGR of 7.23% from 2026 to 2035. Market growth is supported by the increasing global cancer burden, wider use of minimally invasive radiation therapy, and continued investment in oncology treatment infrastructure. HDR and LDR brachytherapy are increasingly used in prostate, breast, cervical, and other cancers where localized radiation delivery can limit exposure to surrounding healthy tissue.

Technology development is also improving treatment precision. Real-time imaging, AI-supported treatment planning, electronic brachytherapy, and outpatient HDR protocols are helping radiation oncology centers improve workflow efficiency and patient management.


Download the Brachytherapy Market Sample Report: https://www.snsinsider.com/sample-request/6535

Brachytherapy Market Highlights

  • Market size, 2025: USD 1,092.0 Million
  • Market size, 2026E: USD 1,171 Million
  • Market forecast, 2035: USD 2,194 Million
  • CAGR: 7.23% from 2026 to 2035
  • Largest region: North America, approximately 46.60% share in 2025
  • Fastest-growing region: Asia Pacific, approximately 7.95% CAGR
  • Largest dosage segment: High-Dose Rate brachytherapy, approximately 73.40% share in 2025
  • Largest product segment: Applicators & Afterloaders, approximately 45.20% share in 2025
  • Largest application: Prostate cancer, approximately 33.15% share in 2025
  • Fastest-growing application: Breast cancer, approximately 7.73% CAGR

Market Relevance

Brachytherapy provides localized radiation directly within or close to a tumor, allowing clinicians to deliver a concentrated dose while limiting radiation exposure to surrounding tissue. This treatment approach remains important in prostate, cervical, breast, and selected skin cancer procedures.

The move toward shorter outpatient treatment protocols is increasing the clinical relevance of HDR brachytherapy. Electronic brachytherapy systems are also creating an alternative to isotope-based treatment in selected indications, reducing some radiation-handling and infrastructure requirements.

Brachytherapy Market Overview

The Brachytherapy Market includes High-Dose Rate and Low-Dose Rate systems, applicators, afterloaders, radioactive seeds, and electronic brachytherapy technologies.

HDR brachytherapy remains widely used because treatment can be completed using concentrated radiation doses delivered over relatively short sessions. LDR approaches remain established in applications such as permanent prostate seed implantation.

Electronic brachytherapy is gaining interest because miniaturized X-ray sources can provide localized treatment without conventional radioactive isotopes. Image-guided applicators and AI-supported treatment planning are also improving dose placement and treatment accuracy.

Strategic Market Outlook

Growth opportunities are developing around electronic brachytherapy, image-guided treatment, outpatient HDR protocols, and expansion of oncology centers in emerging markets. Asia Pacific is particularly important as China, India, and Japan increase cancer treatment capacity.

A shortage of trained specialists and limited availability of dedicated brachytherapy infrastructure remain significant restraints. Brachytherapy procedures require specialized planning, source placement, imaging equipment, and radiation safety expertise, which can limit adoption in lower-resource healthcare systems.

Brachytherapy Market Regional Analysis

North America held approximately 46.60% of the global Brachytherapy Market in 2025, making it the largest region. The United States represented approximately 82.5% of North American revenue, supported by established oncology infrastructure, reimbursement coverage, and clinical use of both HDR and LDR procedures.

The U.S. Brachytherapy Market was valued at approximately USD 346.6 Million in 2025 and is expected to reach approximately USD 594.3 Million by 2035, growing at a CAGR of approximately 5.54%.

The Europe Brachytherapy Market was valued at USD 273.0 Million in 2025 and is expected to reach USD 526.6 Million by 2035, growing at a CAGR of 6.79% from 2026 to 2035. The region remains an established brachytherapy market supported by developed radiation oncology networks and clinical guideline adoption. Germany accounted for approximately 24.6% of European revenue in 2025, while France and the United Kingdom also represent significant markets.

Asia Pacific is expected to be the fastest-growing region, with an estimated CAGR of approximately 7.95%. China accounted for approximately 40.6% of Asia Pacific revenue in 2025, supported by expansion of oncology centers, healthcare investment, and increasing access to radiotherapy. India and Japan are also contributing to regional growth.

Middle East & Africa: The UAE accounted for approximately 22.8% of regional revenue in 2025, supported by improving oncology infrastructure.

Latin America: Brazil accounted for approximately 43.8% of regional revenue in 2025, supported by expanding cancer treatment capacity.

Buy the Brachytherapy Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/6535

Brachytherapy Market Segmentation Analysis

By Dosage: High-Dose Rate brachytherapy held approximately 73.40% market share in 2025, supported by short treatment sessions, outpatient use, and precise radiation delivery. Low-Dose Rate brachytherapy is the faster-growing alternative, with continued use in permanent prostate seed implantation using sources such as Iodine-125 and Palladium-103.

By Product: Applicators & Afterloaders accounted for approximately 45.20% of the market in 2025, reflecting their central role in accurate source positioning and HDR radiation delivery. Electronic brachytherapy is among the fastest-growing product categories, supported by increasing interest in systems that use miniaturized X-ray sources instead of radioactive isotopes.

By Application: Prostate cancer dominated with approximately 33.15% market share in 2025. Breast cancer is expected to grow fastest at approximately 7.73% CAGR, supported by increasing use of localized radiation approaches and outpatient treatment protocols.

Key Industry Trends

  • Increasing adoption of outpatient HDR brachytherapy
  • Growing use of electronic brachytherapy systems
  • Integration of real-time imaging into treatment delivery
  • Increasing use of AI-supported treatment planning
  • Expansion of oncology centers across Asia Pacific
  • Growing interest in non-oncology brachytherapy applications
  • Wider adoption of minimally invasive targeted radiation therapy

Competitive Landscape

The Brachytherapy Market includes radiation oncology equipment manufacturers, isotope suppliers, applicator developers, electronic brachytherapy companies, and treatment-planning technology providers. Competition is increasingly focused on precise dose delivery, image guidance, outpatient treatment capability, electronic brachytherapy, and workflow efficiency.

Major key players include

  • Elekta AB
  • Varian Medical Systems, Inc.
  • Isoray Inc.
  • Becton, Dickinson and Company (BD)
  • Eckert & Ziegler BEBIG
  • CIVCO Radiotherapy
  • Boston Scientific Corporation
  • Theragenics Corporation
  • iCAD, Inc.
  • GT Medical Technologies
  • Huiheng Medical, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Sensus Healthcare, Inc.
  • Oncura, Inc.
  • Nucletron B.V. (An Elekta Company)
  • C4 Imaging LLC
  • Radiation Products Design, Inc.
  • BEBIG Medical GmbH
  • IsoAid LLC
  • K&S Associates, Inc.

Explore the Complete Brachytherapy Market Report: https://www.snsinsider.com/reports/brachytherapy-market-6535

CONTACT: About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com